리제네론 파마슈티컬스 (REGN)

Regeneron Pharmaceuticals, Inc. (REGN) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	2.13% 3,434.30	3,362.70	3,158.10	3,162.10	3,414.40
Operating Expenses	9.31% 2,461.40	2,251.70	2,141.60	2,215.40	2,267.60
Interest Income/Expense	2.81% 18.30	17.80	18.90	18.00	17.40
Benefits Costs and Expenses	1.55% 2,286.70	2,251.90	2,075.20	2,304.10	2,089.70
Costs And Expenses	9.31% 2,461.40	2,251.70	2,141.60	2,215.40	2,267.60
Operating Income/Loss	12.43% 972.90	1,111.00	1,016.50	946.70	1,146.80
Nonoperating Income/Loss	87,450% 174.70	-0.20	66.40	-88.70	177.90
Income/Loss From Continuing Operations Before Tax	3.31% 1,147.60	1,110.80	1,082.90	858.00	1,324.70
Income Tax Expense/Benefit	111.65% -12.00	103.00	114.50	40.20	127.60
Income/Loss From Continuing Operations After Tax	15.06% 1,159.60	1,007.80	968.40	817.80	1,197.10
Net Income/Loss	15.06% 1,159.60	1,007.80	968.40	817.80	1,197.10
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	100.09% -0.10	106.30	107.00	107.10	-0.10
Diluted Average Shares	100.00% -	113.40	113.90	114.00	0.20
Basic Earnings Per Share	14.87% 10.89	9.48	9.05	7.64	11.21
Diluted Earnings Per Share	14.74% 10.20	8.89	8.50	7.17	10.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-